|
2026
|
G/S
|
Providing scientific information, news, and commentary in the field of pharmaceuticals; Providing... |
|
|
G/S
|
Business administration services, namely, business administration of a program to provide access ... |
|
|
G/S
|
Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmace... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuro... |
|
|
G/S
|
Downloadable software for providing medical and pharmaceutical information and managing medical a... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of myasthenia gravis, autoimmune, and neuromuscular... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of lipodystrophy and connective tissue, metabolic, ... |
|
|
G/S
|
Production of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, p... |
|
|
Invention
|
Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta e (i... |
|
|
Invention
|
Methods of treating inflammatory conditions.
The present invention provides methods for treating... |
|
|
Invention
|
Devices and methods for precision dose delivery.
Disclosed herein are delivery devices for deliv... |
|
|
Invention
|
Genetically modified major histocompatibility complex mice.
The invention provides genetically m... |
|
|
Invention
|
Vegf traps and mini-traps and methods for treating ocular disorders and cancer.
The present rela... |
|
|
G/S
|
Medical apparatuses, namely, catheters, combination drug delivery devices sold empty, infusion ap... |
|
|
Invention
|
Methods for treating or preventing asthma by administering an il-4r antagonist.
The invention pr... |
|
|
Invention
|
Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antag... |
|
|
Invention
|
Human serum albumin in formulations.
Drug formulations and methods for removing, reducing, or pr... |
|
|
Invention
|
Pdcd-1 homing endonuclease variants.
The present disclosure provides improved homing endonucleas... |
|
|
Invention
|
Genetically modified t cell receptor mice.
The invention provides a genetically modified non-hum... |
|
|
Invention
|
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging.
Radiolabeled anti-PD-L1 antibodies an... |
|
|
Invention
|
Assembly line with integrated electronic visual inspection.
Methods and systems are disclosed fo... |
|
|
Invention
|
Stabilized formulations containing anti-angptl3 antibodies.
The present invention provides stabl... |
|
|
Invention
|
Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of... |
|
|
Invention
|
Metabolically optimized cell culture.
Improved methods for large scale production of proteins an... |
|
|
Invention
|
High concentration vegf receptor fusion protein containing buffer free formulations. The present ... |
|
2025
|
Invention
|
Characterization of impurities in adeno-associated virus (aav) samples and formulation compositio... |
|
|
Invention
|
Fixed seed train schedule for improved protein production.
The present invention generally perta... |
|
|
Invention
|
Assembly system and related methods of use. In one instance, disclosed herein is a system for ass... |
|
|
Invention
|
Fixed seed train schedule for improved protein production. The present invention generally pertai... |
|
|
Invention
|
Assembly system and related methods of use.
In one instance, disclosed herein is a system for as... |
|
|
Invention
|
Methods of treatment and prevention of post-surgical thrombosis or disorders using factor xi (fxi... |
|
|
Invention
|
Engineered single domain antibody constructs and methods of use thereof. The present disclosure r... |
|
|
Invention
|
Engineered single domain antibody constructs and methods of use thereof.
The present disclosure ... |
|
|
Invention
|
Treatment of cardiac sarcoidosis with interleukin-1 receptor-fc fusion protein. Disclosed herein ... |
|
|
Invention
|
Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders secondary ... |
|
|
Invention
|
Treatment of decreased bone mineral density with zinc and ring finger 3 (znrf3) inhibitors.
The ... |
|
|
Invention
|
Methods of treating cancer with a combination of a cancer vaccine and a taaxcd28 bispecific antig... |
|
|
Invention
|
Heterodimeric antigen-binding molecules that bind to viral particles and uses thereof. The presen... |
|
|
Invention
|
Methods for treating atopic dermatitis by administering an il-4r antagonist.
The present inventi... |
|
|
Invention
|
Systems and methods for drug delivery to ocular tissue. Disclosed are devices and methods for dir... |
|
|
Invention
|
Systems and methods for drug delivery to ocular tissue.
Disclosed are devices and methods for di... |
|
|
Invention
|
Anti-cd3 antibodies, bispecific antigen-binding molecules that bind cd3 and cd20, and uses thereo... |
|
|
Invention
|
Humanized stathmin2 allele to track human tdp-43-dependent splicing changes caused by tdp-43 path... |
|
|
Invention
|
High dose vegf antagonists for treatment of angiogenic eye disorders secondary to retinal vein oc... |
|
|
Invention
|
Multispecific antigen-binding molecules that bind cd22 and 4-1bb and methods of use thereof.
The... |
|
|
Invention
|
Methods of treating multiple myeloma with bcma inhibitors in combination with proteasome inhibito... |
|
|
Invention
|
Methods of treating multiple myeloma with bcma inhibitors in combination with pd1/pd-l1 inhibitor... |
|
|
Invention
|
Methods of treating multiple myeloma with bcma inhibitors in combination with lag3 inhibitors.
T... |
|
|
Invention
|
Methods of treating multiple myeloma with bcma inhibitors in combination with an immunomodulator.... |
|
|
Invention
|
Anti-slc3a2-apis antigen-binding proteins and methods of use thereof.
The present disclosure pro... |
|
|
Invention
|
Tumor-targeted split il2 receptor agonists.
The present disclosure relates to tumor-targeted spl... |
|
|
Invention
|
Compositions and methods for transgene expression from an albumin locus.
The present disclosure ... |
|
|
Invention
|
Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (i... |
|
2024
|
Invention
|
Transcriptome signature analysis for treating inflammation. The present disclosure provides metho... |
|
2023
|
Invention
|
Chimeric proteins comprising membrane bound il-12 with protease cleavable linkers.
The present d... |
|
|
Invention
|
Compositions and methods comprising programmable snrnas for rna editing.
SnRNA systems comprisin... |
|
|
Invention
|
Viral peptides and uses thereof.
The present disclosure provides isolated peptides derived from ... |
|
2012
|
Invention
|
Genetically modified major histocompatibility complex mice. The invention provides genetically mo... |
